Showing 481-490 of 4166 results for "".
Getting Up to Speed on Corneal Transplant Options
https://modernod.com/topics/technology/getting-up-to-speed-on-corneal-transplant-options/37902/Lamellar surgical options are replacing full-thickness grafts for many indications.Updates In Dry Eye Disease: Diagnosing and Treating Patients with Ocular Surface Disease
https://modernod.com/topics/ocular-surface/updates-in-dry-eye-disease-diagnosing-and-treating-patients-with-ocular-surface-disease/37935/Today’s Perspectives on Myopia Management
https://modernod.com/topics/myopia/todays-perspectives-on-myopia-management/38830/Important insights from those in the trenches treating the condition.Specialty Lenses and Corneal Disease
https://modernod.com/mod-issues/marchapril-2025-supplement/specialty-lenses-and-corneal-disease/38946/Guidance on patient suitability, indications for wear, fitting processes, and more.Papilledema Associated With Meningioma
https://modernod.com/topics/neuro-optometry/papilledema-associated-with-meningioma/38793/Even if you suspect idiopathic intracranial hypertension, it’s important to order appropriate imaging and workup to rule out more serious causes of papilledema.Continuing the Dry Eye Conversation
https://modernod.com/podcasts/to-the-point/continuing-the-dry-eye-conversation/54334/Kicking off the first episode of the To the Point podcast in 2026, co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, continue the dry eye conversation with DED pearls to implement in clinic. They cover everything from patient signs, symptoms, and side effects to in-office tools, treatLenz Therapeutics' Vizz Commerically Launched
https://modernod.com/podcasts/eyewire-news-the-podcast/lenz-therapeutics-vizz-commerically-launched/39874/A first-of-its-kind presbyopia eye drop is now commercially available; Lumibird introduces ICL Guru Integration on its ultrasound platform; and the makers of gene therapy candidates for retinal diseases provide clinical updates. Learn more about your ad choices. Visit megaphone.fm/adchoicesAlcon Launches PanOptix Pro in US
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-launches-panoptix-pro-in-us/37078/Alcon introduces its next-generation trifocal IOL; Alcon announces a deal to advance its clinical-stage allogeneic cell therapy; and Bausch + Lomb announces a voluntary recall of IOLs on its enVista platform. Learn more about your ad choices. Visit megaphone.fm/adchoicesNorlase Launches First Pattern Scanning LIO
https://modernod.com/podcasts/eyewire-news-the-podcast/norlase-launches-first-pattern-scanning-lio/37069/The world’s first and only pattern scanning laser indirect ophthalmoscope is approved in the US and Europe; the European Commission approves a biosimilar to Eylea; and we review several clinical updates in the development of ophthalmic drugs. Learn more about your ad choices. Visit megaphone.fm/adchGlaukos Submits NDA for Epi-On CLX Candidate
https://modernod.com/podcasts/eyewire-news-the-podcast/glaukos-submits-nda-for-epi-on-clx-candidate/37066/Glaukos submits a new drug application to the FDA for its next-generation cross-linking therapy; Regeneron releases phase 3 results for Eylea HD for RVO; and Regeneron acquires a clinical stage biotech making ocular delivery technology for retinal disorders. Learn more about your ad choices. Visit m